The impact of comprehensive local therapy on treatment outcomes of non-small cell lung cancer with solitary skeletal oligometastasis [PDF]
Journal of Bone OncologyBackground: The oligometastatic status of non-small lung cancer (NSCLC) has been extensively studied over the years owing to its potential significance in long-term survival. Bone is one of the most commonly affected organs in oligometastatic NSCLC.
Jia-nan Jin +4 more
doaj +3 more sources
Folia Neuropathologica, 2023 Lung adenocarcinoma remains one of the most frequent and deadly tumour entities. Early-stage lung adenocarcinoma is extremely difficult to detect and is also easy to recur or metastasize after treatment.
Kai Xu +4 more
doaj +2 more sources
Cancer Medicine, 2023 Background and Purpose To identify anatomic prognostic factors and their potential roles in refining M1 classification for de novo metastatic nasopharyngeal carcinoma (M1‐NPC).
Tian‐Zhu Lu +13 more
doaj +2 more sources
Lung Radiofrequency Ablation: Potential as a Therapy to Oligometastasis and Oligo-Recurrence [PDF]
Pulmonary Medicine, 2012 The early results (e.g., patient survival) of RFA for the treatment of patients with NSCLC and pulmonary metastasis from various primary lesions including colorectal cancer, lung cancer, hepatocellular carcinoma, renal cell carcinoma, and sarcoma appear ...
Takao Hiraki, Susumu Kanazawa
doaj +2 more sources
Long-term survival after multimodal treatment involving radiotherapy for huge hepatocellular carcinoma with oligometastasis: a case report [PDF]
Journal of Liver Cancer, 2021 The clinical efficacy of local ablative treatment for oligometastasis is widely accepted in most cancers. However, due to limited data, this has not been the case for hepatocellular carcinoma (HCC).
Byung Min Lee, Jinsil Seong
doaj +3 more sources
International Journal of HyperthermiaObjectives To evaluate the efficacy and safety of microwave ablation (MWA) for T1N1M0 PTC with LN oligometastasis (≤3).Materials and Methods In this retrospective study, 41 patients who underwent MWA for T1N1M0 PTC with LN oligometastasis between June ...
Zhenlong Zhao +7 more
doaj +2 more sources
Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer
Pulmonary Medicine, 2012 Oligometastatic Non-Small Cell Lung Cancer (NSCLC) presents a unique opportunity for potential curative therapy. Improved cancer staging using PET/CT, MRI, and future cellular and molecular staging with circulating tumor cells and/or molecular markers ...
Daniel R. Gomez +2 more
doaj +2 more sources
Practical management of oligometastatic gastric cancer
ESMO Gastrointestinal OncologyGastric cancer is one of the types of cancer with a high prevalence of morbidity. The frequency of esophagogastric junction cancer, 5-year survival rates, perioperative adjuvant therapy, and standard chemotherapeutic regimens for gastric cancer vary ...
Y. Narita, K. Muro, D. Takahari
doaj +2 more sources
Treatment Outcomes and Significance of Multimodal Treatment in Esophageal Squamous Cell Carcinoma with Synchronous Oligometastasis. [PDF]
Cancers (Basel)Background/Objectives: Synchronous oligometastasis in stage IVB esophageal squamous cell carcinoma (ESCC) may represent an intermediate state in which local therapy remains effective. However, its definition is still debated, and outcome data are limited.
Ohsawa M +5 more
europepmc +2 more sources
Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type [PDF]
Journal of Urologic Oncology, 2023 Renal cell carcinoma (RCC) has traditionally been considered one of the most radioresistant tumors based on in vitro and clinical studies that utilized a low biologically effective dose.
Chan Woo Wee, Jaeho Cho
doaj +1 more source